Study of Eteplirsen in DMD Patients

Clinical trial NCT02255552 · COMPLETED

Trial details

NCT number: NCT02255552
Sponsor: Sarepta Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Duchenne Muscular Dystrophy (DMD)

Start date: 2014-11-17
Primary completion: 2019-06-14
Enrollment: 109

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.